Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Crosslife Technologies Inc. in June, 2020 for $299,945.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA250663-01 | Phase I | 299,945 | June 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Crosslife Technologies Inc. in September, 2019 for $999,841.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK123849-01 | Phase II | 999,841 | September 15, 2019 | |||||||
A SBIR Phase II contract was awarded to Crosslife Technologies Inc. in August, 2018 for $1,995,562.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI124779-02 | Phase II | 1,995,562 | August 27, 2018 | |||||||
A SBIR Phase I contract was awarded to Crosslife Technologies Inc. in April, 2019 for $299,766.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI145810-01 | Phase I | 299,766 | April 15, 2019 | |||||||
A SBIR Phase II contract was awarded to Crosslife Technologies Inc. in January, 2021 for $999,916.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44TR003549-01 | Phase II | 999,916 | January 15, 2021 | |||||||
A SBIR Phase II contract was awarded to Crosslife Technologies Inc. in August, 2021 for $999,799.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI140813-02 | Phase II | 999,799 | August 13, 2021 | |||||||
A SBIR Phase I contract was awarded to Crosslife Technologies Inc. in March, 2019 for $299,410.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI140813-01A1 | Phase I | 299,410 | March 15, 2019 | |||||||
A SBIR Phase I contract was awarded to Crosslife Technologies Inc. for $299,974.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93019C00026 | Phase I | 299,974 | ||||||||
A SBIR Phase I contract was awarded to Crosslife Technologies Inc. for $299,987.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N91019C00055 | Phase I | 299,987 | ||||||||
A SBIR Phase I contract was awarded to Crosslife Technologies Inc. for $216,444.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 272201800020C-0-0-0 | Phase I | 216,444 | ||||||||
A SBIR Phase I contract was awarded to Crosslife Technologies Inc. for $149,956.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 75D30118PO1938 | Phase I | 149,956 | ||||||||
A SBIR Phase I contract was awarded to Crosslife Technologies Inc. in July, 2016 for $282,084.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI126927-01 | Phase I | 282,084 | July 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Crosslife Technologies Inc. in May, 2016 for $306,564.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43TR001319-01A1 | Phase I | 306,564 | May 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Crosslife Technologies Inc. in January, 2017 for $299,574.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI129077-01 | Phase I | 299,574 | January 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Crosslife Technologies Inc. in May, 2015 for $345,232.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43TR001271-01 | Phase I | 345,232 | May 20, 2015 | |||||||
A SBIR Phase I contract was awarded to Crosslife Technologies Inc. in July, 2016 for $281,515.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI124779-01A1 | Phase I | 281,515 | July 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Crosslife Technologies Inc. in June, 2017 for $224,929.0 USD from the National Science Foundation. | SBIR | 1720900 | Phase I | 224,929 | June 1, 2017 | |||||||
A SBIR Phase II contract was awarded to Crosslife Technologies Inc. in September, 2023 for $994,004.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA250663-02 | Phase II | 994,004 | September 22, 2023 |